Evidence map›Paper›PMID 31015923›Full record

ArticleChemical science2019

Photocatalytic C-H silylation of heteroarenes by using trialkylhydrosilanes.

Shihui Liu, Peng Pan, Huaqiang Fan, Hao Li, Wei Wang, Yongqiang Zhang

Abstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shihui LiuState Key Laboratory of Bioengineering Reactor , Shanghai Key Laboratory of New Drug Design and School of Pharmacy , East China University of Science and Technology , Shanghai 200237 , P. R. China . Email: yongqiangzhang@ecust.edu.cn ; Email: wwang@pharmacy.arizona.edu.
Peng PanState Key Laboratory of Bioengineering Reactor , Shanghai Key Laboratory of New Drug Design and School of Pharmacy , East China University of Science and Technology , Shanghai 200237 , P. R. China . Email: yongqiangzhang@ecust.edu.cn ; Email: wwang@pharmacy.arizona.edu.
Huaqiang FanState Key Laboratory of Bioengineering Reactor , Shanghai Key Laboratory of New Drug Design and School of Pharmacy , East China University of Science and Technology , Shanghai 200237 , P. R. China . Email: yongqiangzhang@ecust.edu.cn ; Email: wwang@pharmacy.arizona.edu.
Hao LiState Key Laboratory of Bioengineering Reactor , Shanghai Key Laboratory of New Drug Design and School of Pharmacy , East China University of Science and Technology , Shanghai 200237 , P. R. China . Email: yongqiangzhang@ecust.edu.cn ; Email: wwang@pharmacy.arizona.edu.ORCID 0000-0002-8978-0247
Wei WangState Key Laboratory of Bioengineering Reactor , Shanghai Key Laboratory of New Drug Design and School of Pharmacy , East China University of Science and Technology , Shanghai 200237 , P. R. China . Email: yongqiangzhang@ecust.edu.cn ; Email: wwang@pharmacy.arizona.edu.ORCID 0000-0001-6043-0860
Yongqiang ZhangState Key Laboratory of Bioengineering Reactor , Shanghai Key Laboratory of New Drug Design and School of Pharmacy , East China University of Science and Technology , Shanghai 200237 , P. R. China . Email: yongqiangzhang@ecust.edu.cn ; Email: wwang@pharmacy.arizona.edu.ORCID 0000-0002-7210-4787

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficient and selective C-H silylation of heteroarenes, especially the pharmaceutically relevant electron-deficient heteroarenes, represents a great challenge in organic synthesis. Herein we wish to report a distinctive visible light-promoted photocatalytic C-H silylation approach that enables the direct coupling of trialkylhydrosilanes with both electron-deficient and -rich heteroarenes as well as with cyano-substituted arenes in moderate to high yields and with good regioselectivity. The protocol features operational simplicity, mild reaction conditions, and the use of safe and readily available Na

Identifiers

PMID31015923
PMCPMC6457191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.